SENTIX – A prospective observational trial on sentinel lymph node biopsy in patients with early stage cervical cancer, CEEGOG – Central and Eastern European Gynaecologic Oncology Group. Consent of Independent Bioethical Committee for Scientific Research at the Medical University of Gdańsk – NKBBN/389/2016 – active recruitment.

NACOPRAD – PROSPEKTIV RANDOMISIERTE, MULTIZENTRISCHE STUDIE ZUM VERGLEICH DER EINERRADIKALEN HYSTEREKTOMIE NACHNEOADJUVANTER CHEMOTHERAPIE VERSUS EINER PRIMAREN RADIOCHEMOTHERAPIE BEI PATIENTINNEN MIT EINEM ZERVIXKARZINOM DER FIGO – STADIEN IB2 UND IIB, ARO–NOGGO–AGO – Studien kooperation. Eudra CT–Nr.: 2017–003221–15. Clinical Trials Number: NCT02422563. (A prospective multi–centre randomized trial for the purpose of comparing radical uterine eradication after neoadjuvant chemotherapy with primary chemoradiation in patients with cervical cancer at the advanced stages of IB2 and IIB according to the FIGO classification standards). Sponsored by University of Koln, Germany. Consent of Independent Bioethical Committee for Scientific Research at the Medical University of Gdańsk – NKBBN/633/2018.